Lantheus Holdings (LNTH) Shareholder's Equity (2013 - 2026)

Lantheus Holdings (LNTH) Shareholder's Equity (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 8.23 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 3.23 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 5.90 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 407.18 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 3.41 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.50 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 1.75 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.21 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 446.17 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 108.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.21 Bn
Dec 31, 2025 1.09 Bn
Sep 30, 2025 1.12 Bn
Jun 30, 2025 1.17 Bn
Mar 31, 2025 1.16 Bn
Dec 31, 2024 1.09 Bn
Sep 30, 2024 1.18 Bn
Jun 30, 2024 1.03 Bn
Mar 31, 2024 945.54 Mn
Dec 31, 2023 815.89 Mn
Sep 30, 2023 698.76 Mn
Jun 30, 2023 552.65 Mn
Mar 31, 2023 445.52 Mn
Dec 31, 2022 447.15 Mn
Sep 30, 2022 638.05 Mn
Jun 30, 2022 567.33 Mn
Mar 31, 2022 515.85 Mn
Dec 31, 2021 464.44 Mn
Sep 30, 2021 499.34 Mn
Jun 30, 2021 508.14 Mn